Vytrus Biotech, S.A. (BME:VYT)

Vytrus Biotech Revenue

In the year 2024, Vytrus Biotech had annual revenue of 6.09M EUR with 29.51% growth. Vytrus Biotech had revenue of 3.06M in the half year ending December 31, 2024, with 46.56% growth.

• Revenue: 6.09M
• Revenue Growth: +29.51%
• P/S Ratio: 6.79
• Revenue / Employee: 164.60K
• Employees: 37
• Market Cap: 41.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.09M	1.39M	29.51%
Dec 31, 2023	4.70M	219.70K	4.90%
Dec 31, 2022	4.48M	968.83K	27.57%
Dec 31, 2021	3.51M	1.28M	57.47%
Dec 31, 2020	2.23M	456.81K	25.74%